These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 27657335

  • 1. Dengue Protease Substrate Recognition: Binding of the Prime Side.
    Lin KH, Nalivaika EA, Prachanronarong KL, Yilmaz NK, Schiffer CA.
    ACS Infect Dis; 2016 Oct 14; 2(10):734-743. PubMed ID: 27657335
    [Abstract] [Full Text] [Related]

  • 2. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH, Ali A, Rusere L, Soumana DI, Kurt Yilmaz N, Schiffer CA.
    J Virol; 2017 May 15; 91(10):. PubMed ID: 28298600
    [Abstract] [Full Text] [Related]

  • 3. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
    Murthy HM, Judge K, DeLucas L, Padmanabhan R.
    J Mol Biol; 2000 Aug 25; 301(4):759-67. PubMed ID: 10966782
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor.
    Brinkworth RI, Fairlie DP, Leung D, Young PR.
    J Gen Virol; 1999 May 25; 80 ( Pt 5)():1167-1177. PubMed ID: 10355763
    [Abstract] [Full Text] [Related]

  • 9. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
    Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U.
    Nat Struct Mol Biol; 2006 Apr 25; 13(4):372-3. PubMed ID: 16532006
    [Abstract] [Full Text] [Related]

  • 10. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
    Chanprapaph S, Saparpakorn P, Sangma C, Niyomrattanakit P, Hannongbua S, Angsuthanasombat C, Katzenmeier G.
    Biochem Biophys Res Commun; 2005 May 20; 330(4):1237-46. PubMed ID: 15823576
    [Abstract] [Full Text] [Related]

  • 11. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.
    Khumthong R, Niyomrattanakit P, Chanprapaph S, Angsuthanasombat C, Panyim S, Katzenmeier G.
    Protein Pept Lett; 2003 Feb 20; 10(1):19-26. PubMed ID: 12625822
    [Abstract] [Full Text] [Related]

  • 12. Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: A molecular dynamics Study.
    Yotmanee P, Rungrotmongkol T, Wichapong K, Choi SB, Wahab HA, Kungwan N, Hannongbua S.
    J Mol Graph Model; 2015 Jul 20; 60():24-33. PubMed ID: 26086900
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H, Teramoto T, Padmanabhan R.
    Methods Mol Biol; 2014 Jul 20; 1138():345-60. PubMed ID: 24696347
    [Abstract] [Full Text] [Related]

  • 15. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
    Niyomrattanakit P, Winoyanuwattikun P, Chanprapaph S, Angsuthanasombat C, Panyim S, Katzenmeier G.
    J Virol; 2004 Dec 20; 78(24):13708-16. PubMed ID: 15564480
    [Abstract] [Full Text] [Related]

  • 16. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U, Tomlinson SM, Fonner JM, Mock SA, Watowich SJ.
    J Chem Inf Model; 2014 Oct 27; 54(10):2816-25. PubMed ID: 25263519
    [Abstract] [Full Text] [Related]

  • 17. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K, Pianwanit S, Sippl W, Kokpol S.
    J Mol Recognit; 2010 Oct 27; 23(3):283-300. PubMed ID: 19693793
    [Abstract] [Full Text] [Related]

  • 18. Product release is rate-limiting for catalytic processing by the Dengue virus protease.
    Shannon AE, Pedroso MM, Chappell KJ, Watterson D, Liebscher S, Kok WM, Fairlie DP, Schenk G, Young PR.
    Sci Rep; 2016 Nov 29; 6():37539. PubMed ID: 27897196
    [Abstract] [Full Text] [Related]

  • 19. Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects.
    Murthy HM, Clum S, Padmanabhan R.
    J Biol Chem; 1999 Feb 26; 274(9):5573-80. PubMed ID: 10026173
    [Abstract] [Full Text] [Related]

  • 20. Discovering key residues of dengue virus NS2b-NS3-protease: New binding sites for antiviral inhibitors design.
    Aguilera-Pesantes D, Robayo LE, Méndez PE, Mollocana D, Marrero-Ponce Y, Torres FJ, Méndez MA.
    Biochem Biophys Res Commun; 2017 Oct 28; 492(4):631-642. PubMed ID: 28343993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.